< back to search

Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study.

Deodhar, Atul   •   Reveille, John D   •   Harrison, Diane D   •   Kim, Lilianne   •   Lo, Kim Hung   •   Leu, Jocelyn H   •   Hsia, Elizabeth C

published in: The Journal of rheumatology



endpoint

Golimumab has (optional: compared with placebo) proved to be better.
general condition better


basics

diagnosis:
ankylosing spondylitis

localization:
not specified

method:
conservative therapy → injection
conservative therapy → injection therapy

publication details

10.3899/jrheum.170487
pubmed
29247154
2018
Journal Article
randomized controlled trial
yes
prospective
1+

▼
▲